子宫肉瘤的国际妇产科联盟（FIGO）分期 - Suppr

Suppr

超能文献

FIGO staging for uterine sarcomas.

作者信息

Prat Jaime

出版信息

Int J Gynaecol Obstet. 2009 Mar;104(3):177-8. doi: 10.1016/j.ijgo.2008.12.008. Epub 2009 Jan 9.

DOI:10.1016/j.ijgo.2008.12.008

PMID:19135669

Abstract

摘要

相似文献

FIGO staging for uterine sarcomas.

Int J Gynaecol Obstet. 2009 Mar;104(3):177-8. doi: 10.1016/j.ijgo.2008.12.008. Epub 2009 Jan 9.

Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.

Hum Pathol. 2009 Nov;40(11):1571-85. doi: 10.1016/j.humpath.2009.03.018. Epub 2009 Jun 21.

[New FIGO staging for uterine sarcomas].

Pathologe. 2009 Jul;30(4):302-3. doi: 10.1007/s00292-009-1158-8.

Uterine sarcomas: a review.

Gynecol Oncol. 2010 Jan;116(1):131-9. doi: 10.1016/j.ygyno.2009.09.023. Epub 2009 Oct 23.

[Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].

Gynecol Obstet Fertil. 2008 Jun;36(6):628-35. doi: 10.1016/j.gyobfe.2008.03.012. Epub 2008 Jun 5.

Uterine sarcomas.

Int J Gynaecol Obstet. 2015 Oct;131 Suppl 2:S105-10. doi: 10.1016/j.ijgo.2015.06.006.

Staging of uterine sarcomas.

Best Pract Res Clin Obstet Gynaecol. 2011 Dec;25(6):733-49. doi: 10.1016/j.bpobgyn.2011.05.011. Epub 2011 Jul 14.

Uterine sarcomas--recent progress and future challenges.

Eur J Radiol. 2011 Apr;78(1):30-40. doi: 10.1016/j.ejrad.2010.12.057. Epub 2011 Jan 17.

Prognostic factors in uterine sarcoma.

Best Pract Res Clin Obstet Gynaecol. 2011 Dec;25(6):783-95. doi: 10.1016/j.bpobgyn.2011.06.002. Epub 2011 Jul 18.

Uterine sarcomas.

Ann Chir Gynaecol Suppl. 1985;197:11-4.

引用本文的文献

Low-grade endometrial stromal sarcoma: a case report and literature review.

Front Oncol. 2025 Aug 25;15:1652010. doi: 10.3389/fonc.2025.1652010. eCollection 2025.

Clinicopathological Predictors of Recurrence in Uterine Sarcomas-A Narrative Review.

J Clin Med. 2025 Jul 9;14(14):4883. doi: 10.3390/jcm14144883.

Prognostic Role of Radiotherapy in Low-Grade Endometrial Stromal Sarcoma: A SEER-Based Study.

Cancer Control. 2025 Jan-Dec;32:10732748251356935. doi: 10.1177/10732748251356935. Epub 2025 Jun 30.

β-catenin is a Potential Prognostic Biomarker in Uterine Sarcoma.

Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251345208. doi: 10.1177/15330338251345208. Epub 2025 May 21.

Orosomucoid 1 is a Potential Prognostic Biomarker for Uterine Sarcoma.

Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251343487. doi: 10.1177/15330338251343487. Epub 2025 May 19.

Uterine Carcinosarcoma: Adaptation to New FIGO 2023 Staging System Through Clinical Profile and Oncologic Outcomes.

J Clin Med. 2025 Mar 27;14(7):2299. doi: 10.3390/jcm14072299.

Uterine Carcinosarcoma (UCS): A Literature Review and Survival Analysis from a Retrospective Cohort Study.

Cancers (Basel). 2024 Nov 21;16(23):3905. doi: 10.3390/cancers16233905.

Case report: Diagnostic trap: metastatic endometrial stromal sarcoma with breast metastasis.

Front Oncol. 2024 Oct 15;14:1465052. doi: 10.3389/fonc.2024.1465052. eCollection 2024.

NNMT overexpression is an adverse prognostic factor in uterine leiomyosarcoma.

Turk J Med Sci. 2024 Apr 16;54(4):804-810. doi: 10.55730/1300-0144.5852. eCollection 2024.

Clinicopathological and survival analysis for patients with uterine sarcoma treated following surgery for presumed benign disease.

BMC Cancer. 2024 Sep 9;24(1):1118. doi: 10.1186/s12885-024-12881-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

FIGO staging for uterine sarcomas.

Int J Gynaecol Obstet. 2009 Mar;104(3):177-8. doi: 10.1016/j.ijgo.2008.12.008. Epub 2009 Jan 9.

Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.

Hum Pathol. 2009 Nov;40(11):1571-85. doi: 10.1016/j.humpath.2009.03.018. Epub 2009 Jun 21.

[New FIGO staging for uterine sarcomas].

Pathologe. 2009 Jul;30(4):302-3. doi: 10.1007/s00292-009-1158-8.

Uterine sarcomas: a review.

Gynecol Oncol. 2010 Jan;116(1):131-9. doi: 10.1016/j.ygyno.2009.09.023. Epub 2009 Oct 23.

[Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].

Gynecol Obstet Fertil. 2008 Jun;36(6):628-35. doi: 10.1016/j.gyobfe.2008.03.012. Epub 2008 Jun 5.

Uterine sarcomas.

Int J Gynaecol Obstet. 2015 Oct;131 Suppl 2:S105-10. doi: 10.1016/j.ijgo.2015.06.006.

Staging of uterine sarcomas.

Best Pract Res Clin Obstet Gynaecol. 2011 Dec;25(6):733-49. doi: 10.1016/j.bpobgyn.2011.05.011. Epub 2011 Jul 14.

Uterine sarcomas--recent progress and future challenges.

Eur J Radiol. 2011 Apr;78(1):30-40. doi: 10.1016/j.ejrad.2010.12.057. Epub 2011 Jan 17.

Prognostic factors in uterine sarcoma.

Best Pract Res Clin Obstet Gynaecol. 2011 Dec;25(6):783-95. doi: 10.1016/j.bpobgyn.2011.06.002. Epub 2011 Jul 18.

Uterine sarcomas.

Ann Chir Gynaecol Suppl. 1985;197:11-4.

引用本文的文献

Low-grade endometrial stromal sarcoma: a case report and literature review.

Front Oncol. 2025 Aug 25;15:1652010. doi: 10.3389/fonc.2025.1652010. eCollection 2025.

Clinicopathological Predictors of Recurrence in Uterine Sarcomas-A Narrative Review.

J Clin Med. 2025 Jul 9;14(14):4883. doi: 10.3390/jcm14144883.

Prognostic Role of Radiotherapy in Low-Grade Endometrial Stromal Sarcoma: A SEER-Based Study.

Cancer Control. 2025 Jan-Dec;32:10732748251356935. doi: 10.1177/10732748251356935. Epub 2025 Jun 30.

β-catenin is a Potential Prognostic Biomarker in Uterine Sarcoma.

Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251345208. doi: 10.1177/15330338251345208. Epub 2025 May 21.

Orosomucoid 1 is a Potential Prognostic Biomarker for Uterine Sarcoma.

Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251343487. doi: 10.1177/15330338251343487. Epub 2025 May 19.

Uterine Carcinosarcoma: Adaptation to New FIGO 2023 Staging System Through Clinical Profile and Oncologic Outcomes.

J Clin Med. 2025 Mar 27;14(7):2299. doi: 10.3390/jcm14072299.

Uterine Carcinosarcoma (UCS): A Literature Review and Survival Analysis from a Retrospective Cohort Study.

Cancers (Basel). 2024 Nov 21;16(23):3905. doi: 10.3390/cancers16233905.

Case report: Diagnostic trap: metastatic endometrial stromal sarcoma with breast metastasis.

Front Oncol. 2024 Oct 15;14:1465052. doi: 10.3389/fonc.2024.1465052. eCollection 2024.

NNMT overexpression is an adverse prognostic factor in uterine leiomyosarcoma.

Turk J Med Sci. 2024 Apr 16;54(4):804-810. doi: 10.55730/1300-0144.5852. eCollection 2024.

Clinicopathological and survival analysis for patients with uterine sarcoma treated following surgery for presumed benign disease.

BMC Cancer. 2024 Sep 9;24(1):1118. doi: 10.1186/s12885-024-12881-8.